DONALDSON Co INC acquires Isolere Bio, Inc.
Snapshot
DONALDSON Co INC acquired Isolere Bio, Inc. for $62.3 million (net of cash acquired) in February 2023. The transaction was structured as all cash. Isolere Bio, Inc. is a Headquartered in Durham, North Carolina-based Life Sciences business.
- Acquirer
- DONALDSON Co INC
- Target
- Isolere Bio, Inc.
- Value
- $62.3 million (net of cash acquired)
- Date
- February 2023
- Type
- Full acquisition
- Status
- Ready
The deal at a glance
DONALDSON Co INC acquired Isolere Bio, Inc. for $62.3 million (net of cash acquired), a transaction completed in February 2023, structured as all cash.
Isolere Bio, Inc. operates in Life Sciences, is based in Headquartered in Durham, North Carolina. Isolere is an early-stage biotechnology company that developed novel, proprietary IsoTag reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals. Aimed initially at the purification of viral vectors used for cell and gene therapies, IsoTag reagents are designed to substantially improve product quality and purity with faster timelines compared to competing solutions.
Adds proprietary purification chemistry to Donaldson's bioprocessing platform, complementing its filtration-based separation technologies.
Life Sciences segment
No advisory firms have been disclosed for this transaction.